Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma

Shogo Okazaki1,2, Kiyoko Umene1,3, Juntaro Yamasaki1

  • 1Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan.

Cancer Science
|August 25, 2019
PubMed

Insights

Targeting cystine-glutamate antiporter xCT with sulfasalazine shows promise for head and neck cancer. Its efficacy depends on ASCT2 and GLUD, impacting glutathione synthesis and oxidative stress.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Cancer stem-like cells exhibit resistance to therapy via mechanisms like oxidative stress.
  • The cystine-glutamate antiporter xCT is crucial for glutathione synthesis and antioxidant defense in cancer cells.
  • Understanding factors determining sensitivity to xCT-targeted therapy is vital for effective cancer treatment.

Purpose of the Study:

  • To investigate the role of xCT and ASCT2 in head and neck squamous cell carcinoma (HNSCC) differentiation and therapy response.
  • To elucidate the mechanism of sulfasalazine cytotoxicity in HNSCC.
  • To identify biomarkers for predicting efficacy of xCT-targeted therapy.

Main Methods:

  • Analysis of xCT and ASCT2 expression in HNSCC.
  • Assessment of sulfasalazine cytotoxicity in relation to ASCT2 and GLUD.
  • Metabolome analysis to study metabolic alterations upon sulfasalazine treatment.
  • Gene ablation studies (GLUD) to confirm functional roles.

Main Results:

  • High expression of xCT and ASCT2 correlates with undifferentiated HNSCC and decreases with differentiation.
  • Sulfasalazine cytotoxicity is dependent on ASCT2-mediated glutamine uptake and GLUD-driven α-ketoglutarate production.
  • Sulfasalazine treatment reduces cysteine and GSH levels while increasing α-ketoglutarate, leading to ROS generation and oxidative damage.
  • GLUD ablation significantly reduces sulfasalazine's cytotoxicity in CD44v-expressing HNSCC cells.

Conclusions:

  • Sulfasalazine-induced xCT inhibition impairs GSH synthesis and enhances mitochondrial metabolism, causing oxidative damage.
  • ASCT2 and GLUD are critical for sulfasalazine efficacy in HNSCC.
  • Glutamine metabolism-related genes (ASCT2, GLUD) can serve as biomarkers for predicting xCT-targeted therapy response in HNSCC.

Related Concept Videos

Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.0K
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.3K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Muscles of the Anterior Neck01:26

Muscles of the Anterior Neck

The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K